SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

RBC Capital Initiates Coverage On Alnylam Pharmaceuticals with Sector Perform Rating, Announces Price Target of $150

RBC Capital initiates coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Sector Perform rating and announces Price Target of $150.

Benzinga · 05/13/2020 09:06

RBC Capital initiates coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Sector Perform rating and announces Price Target of $150.